TRVI logo

Trevi Therapeutics, Inc. (TRVI) Free Cash Flow

Annual FCF:

-$38.29M-$6.44M(-20.23%)
December 31, 2024

Summary

  • As of today, TRVI annual free cash flow is -$38.29 million, with the most recent change of -$6.44 million (-20.23%) on December 31, 2024.
  • During the last 3 years, TRVI annual free cash flow has fallen by -$9.35 million (-32.28%).
  • TRVI annual free cash flow is now -381.35% below its all-time high of -$7.96 million, reached on December 31, 2017.

Performance

TRVI Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

Quarterly FCF:

-$10.10M+$3.38M(+25.05%)
June 30, 2025

Summary

  • As of today, TRVI quarterly free cash flow is -$10.10 million, with the most recent change of +$3.38 million (+25.05%) on June 30, 2025.
  • Over the past year, TRVI quarterly free cash flow has dropped by -$1.39 million (-15.96%).
  • TRVI quarterly free cash flow is now -146.07% below its all-time high of -$4.11 million, reached on March 31, 2019.

Performance

TRVI Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

TTM FCF:

-$42.69M-$1.39M(-3.37%)
June 30, 2025

Summary

  • As of today, TRVI TTM free cash flow is -$42.69 million, with the most recent change of -$1.39 million (-3.37%) on June 30, 2025.
  • Over the past year, TRVI TTM free cash flow has dropped by -$9.84 million (-29.93%).
  • TRVI TTM free cash flow is now -659.63% below its all-time high of -$5.62 million, reached on June 30, 2018.

Performance

TRVI TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRVIcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TRVI Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-20.2%-16.0%-29.9%
3Y3 Years-32.3%-63.5%-59.7%
5Y5 Years-65.8%-19.6%-62.3%

TRVI Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-35.1%at low-58.3%+25.1%-51.8%at low
5Y5-Year-65.8%at low-63.5%+25.1%-62.3%at low
All-TimeAll-Time-381.4%at low-146.1%+25.1%-659.6%at low

TRVI Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$10.10M(+25.1%)
-$42.69M(-3.4%)
Mar 2025
-
-$13.48M(-41.0%)
-$41.30M(-7.9%)
Dec 2024
-$38.29M(-20.2%)
-$9.56M(-0.0%)
-$38.29M(-9.0%)
Sep 2024
-
-$9.56M(-9.7%)
-$35.12M(-6.9%)
Jun 2024
-
-$8.71M(+16.8%)
-$32.86M(+3.5%)
Mar 2024
-
-$10.47M(-64.0%)
-$34.06M(-6.9%)
Dec 2023
-$31.85M(-12.4%)
-$6.38M(+12.6%)
-$31.85M(+0.2%)
Sep 2023
-
-$7.30M(+26.4%)
-$31.91M(+4.0%)
Jun 2023
-
-$9.91M(-20.1%)
-$33.23M(-12.7%)
Mar 2023
-
-$8.25M(-28.0%)
-$29.50M(-4.1%)
Dec 2022
-$28.33M(+2.1%)
-$6.45M(+25.2%)
-$28.33M(-0.8%)
Sep 2022
-
-$8.62M(-39.6%)
-$28.12M(-5.2%)
Jun 2022
-
-$6.18M(+12.9%)
-$26.74M(+6.1%)
Mar 2022
-
-$7.09M(-13.9%)
-$28.46M(+1.7%)
Dec 2021
-$28.95M
-$6.23M(+14.0%)
-$28.95M(+8.5%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$7.24M(+8.3%)
-$31.65M(-0.8%)
Jun 2021
-
-$7.90M(-4.2%)
-$31.39M(+1.7%)
Mar 2021
-
-$7.58M(+15.1%)
-$31.94M(-10.0%)
Dec 2020
-$29.03M(-25.7%)
-$8.93M(-27.9%)
-$29.03M(-10.4%)
Sep 2020
-
-$6.98M(+17.4%)
-$26.30M(+2.8%)
Jun 2020
-
-$8.45M(-80.8%)
-$27.06M(-14.3%)
Mar 2020
-
-$4.67M(+24.7%)
-$23.67M(-2.5%)
Dec 2019
-$23.10M(-25.0%)
-$6.20M(+19.8%)
-$23.10M(-6.3%)
Sep 2019
-
-$7.73M(-52.8%)
-$21.72M(-55.3%)
Jun 2019
-
-$5.06M(-23.3%)
-$13.99M(+3.8%)
Mar 2019
-
-$4.11M(+14.9%)
-$14.55M(-39.3%)
Dec 2018
-$18.48M(-132.3%)
-$4.82M(+14.2%)
-$10.44M(-85.8%)
Jun 2018
-
-$5.62M
-$5.62M
Dec 2017
-$7.96M(+28.9%)
-
-
Dec 2016
-$11.19M
-
-

FAQ

  • What is Trevi Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is Trevi Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Trevi Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Trevi Therapeutics, Inc.?
  • What is Trevi Therapeutics, Inc. TTM free cash flow year-on-year change?

What is Trevi Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of TRVI is -$38.29M

What is the all-time high annual free cash flow for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high annual free cash flow is -$7.96M

What is Trevi Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, TRVI annual free cash flow has changed by -$6.44M (-20.23%)

What is Trevi Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of TRVI is -$10.10M

What is the all-time high quarterly free cash flow for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high quarterly free cash flow is -$4.11M

What is Trevi Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, TRVI quarterly free cash flow has changed by -$1.39M (-15.96%)

What is Trevi Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of TRVI is -$42.69M

What is the all-time high TTM free cash flow for Trevi Therapeutics, Inc.?

Trevi Therapeutics, Inc. all-time high TTM free cash flow is -$5.62M

What is Trevi Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, TRVI TTM free cash flow has changed by -$9.84M (-29.93%)
On this page